Literature DB >> 18397976

Muscle adaptation to short-term fasting in healthy lean humans.

Maarten R Soeters1, Hans P Sauerwein, Peter F Dubbelhuis, Johanna E Groener, Mariëtte T Ackermans, Eric Fliers, Johannes M Aerts, Mireille J Serlie.   

Abstract

CONTEXT: It has been demonstrated repeatedly that short-term fasting induces insulin resistance, although the exact mechanism in humans is unknown to date. Intramyocellular sphingolipids (i.e. ceramide) have been suggested to induce insulin resistance by interfering with the insulin signaling cascade in obesity.
OBJECTIVE: Our objective was to study peripheral insulin sensitivity together with muscle ceramide concentrations and protein kinase B/AKT phosphorylation after short-term fasting. MAIN OUTCOME MEASURES AND
DESIGN: After 14- and 62-h fasting, glucose fluxes were measured before and after a hyperinsulinemic euglycemic clamp. Muscle biopsies were performed in the basal state and during the clamp to assess muscle ceramide and protein kinase B/AKT.
RESULTS: Insulin-mediated peripheral glucose uptake was significantly lower after 62-h fasting compared with 14-h fasting. Intramuscular ceramide concentrations tended to increase during fasting. During the clamp the phosphorylation of protein kinase B/AKT at serine(473) in proportion to the total amount of protein kinase B/AKT was significantly lower. Muscle ceramide did not correlate with plasma free fatty acids.
CONCLUSIONS: Fasting for 62 h decreases insulin-mediated peripheral glucose uptake with lower phosphorylation of AKT at serine(473). AKT may play a regulatory role in fasting-induced insulin resistance. Whether the decrease in AKT can be attributed to the trend to higher muscle ceramide remains unanswered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397976     DOI: 10.1210/jc.2008-0250

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  No effect of 24 h severe energy restriction on appetite regulation and ad libitum energy intake in overweight and obese males.

Authors:  D J Clayton; M Creese; N Skidmore; D J Stensel; L J James
Journal:  Int J Obes (Lond)       Date:  2016-06-24       Impact factor: 5.095

2.  Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle.

Authors:  M H Vendelbo; B F F Clasen; J T Treebak; L Møller; T Krusenstjerna-Hafstrøm; M Madsen; T S Nielsen; H Stødkilde-Jørgensen; S B Pedersen; J O L Jørgensen; L J Goodyear; J F P Wojtaszewski; N Møller; N Jessen
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-25       Impact factor: 4.310

3.  Impact of Dietary Carbohydrate Restriction versus Energy Restriction on Exogenous Carbohydrate Oxidation during Aerobic Exercise.

Authors:  Stephanie D Small; Lee M Margolis
Journal:  Adv Nutr       Date:  2021-11-12       Impact factor: 8.701

4.  Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance.

Authors:  Joris Hoeks; Noud A van Herpen; Marco Mensink; Esther Moonen-Kornips; Denis van Beurden; Matthijs K C Hesselink; Patrick Schrauwen
Journal:  Diabetes       Date:  2010-06-23       Impact factor: 9.461

5.  The role of skeletal muscle sphingolipids in the development of insulin resistance.

Authors:  Marek Straczkowski; Irina Kowalska
Journal:  Rev Diabet Stud       Date:  2008-05-10

6.  Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues.

Authors:  Marina Makrecka-Kuka; Eduards Sevostjanovs; Karlis Vilks; Kristine Volska; Unigunde Antone; Janis Kuka; Elina Makarova; Osvalds Pugovics; Maija Dambrova; Edgars Liepinsh
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

7.  Proteomic Analysis of Human Plasma during Intermittent Fasting.

Authors:  Dylan J Harney; Amy T Hutchison; Luke Hatchwell; Sean J Humphrey; David E James; Samantha Hocking; Leonie K Heilbronn; Mark Larance
Journal:  J Proteome Res       Date:  2019-04-01       Impact factor: 4.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.